Generics 32

Biosimilars

Medical devices

Nutraceuticals

Filters

Xylometazoline manufacturers

32 products found

Filters

32 products found

xylometazoline

Nasal spray 0.1%

Dossier type
EU CTD
Country of origin
European Union
Dossier status
Ready
GMP approvals
EU GMP
Registered in
Germany

Manufacturer #9438

A pharmaceutical manufacturer based in Europe that has been active in 10+ countries selling its products in Europe for 10+ years. Key production lines are Rx, OTC, dermo-cosmetics, and nutraceuticals. The main therapeutic areas include antibiotics.

Manufacturer usually replies in 3 days

xylometazoline

Nasal spray 0.1%

Dossier type
EU CTD
Country of origin
European Union
Dossier status
Ready
GMP approvals
EU GMP

Manufacturer #17620

It provides high-quality medicinal items for a healthy lifestyle. This has been the company's guiding principle since its inception. Top-quality in all aspects of work is not just a slogan, but a daily reality. From product concept to packaging, the complete development and production process takes place in East Westphalia-Lippe under tight scientific supervision.

Manufacturer usually replies in 7 days

xylometazoline

Nasal drops 0.1 %, 0.05 %

Dossier type
EU CTD
Country of origin
European Union
Dossier status
Ready
GMP approvals
EU GMP
Unavailable markets
Vietnam

Manufacturer #417

A pharmaceutical manufacturer based in the EU that has been active in 30+ countries selling its products in Europe, North America, Middle East, CIS, Africa, Oceania, and Asia for 40+ years. Key production lines are Rx and nutraceuticals. The company's production lines are EU GMP-compliant. Main dosage forms include oral solutions, gels, oral suspensions, and topicals. The company prepares a CTD format dossier.

Manufacturer usually replies in 8 days

Want to view all 32 products? Create your free account today!

Xylometazoline:

Xylometazoline also spelt xylomethazoline, is a medication which is used to alleviate the symptoms of nasal congestion, allergic rhinitis, and sinusitis. It is typically administered by way of a nasal spray or drop and is not recommended for use in those less than three months of age or 6 years, depending on the advisory source. Xylometazoline was originally produced by a pharmaceutical products manufacturing company and subsequently patented in 1956. It gained regulatory approval for sale on the medical marketplace in 1959 and is currently listed on the World Health Organization's List of Essential Medicines. Indicating it as a cost-effective and efficient medication recommended for use in global health systems. This has been spurred by its entry into the generic drugs space, making it popular for xylometazoline manufacturers and xylometazoline suppliers to list for sale. Where it can commonly be found available to order in the pharmaceutical products lists of global distributors, at wholesale for a variety of cost and price points.

Method of action of Xylometazoline:

Xylometazoline belongs to a group of drugs termed direct-acting sympathomimetics. These medications act on the alpha-adrenergic receptors in the arterioles of the nasal mucosa. This activates the adrenal system to result in systemic vasoconstriction which subsequently decreases the blood flow in the nasal passage. Decreasing nasal congestion.

Form and dosage of xylometazoline:

The final form and packaging of xylometazoline are dependent on the manufacturers and suppliers, as well as the specific distributors and order. However as xylometazoline is administered nasally, it can predominantly be found wholesale in forms including nasal spray and nasal drops. The recommended dose for adults in drop form is 2–3 drops 2–3 times a day as required for a maximum duration of 7 days (0.1% solution). For intranasal administration using nasal spray, 1 spray 1–3 times a day as required for a maximum duration of 7 days in each nostril is recommended. For more information please contact a healthcare professional or refer to the manufacturers’ literature.

Xylometazoline on Pipelinepharma:

Currently, at the time of writing, we have found 21 verified xylometazoline manufacturers and xylometazoline suppliers from our global list of sellers. These manufacturers, suppliers, and distributors are located in various countries including the European Union, Ukraine, and Jordan. Each company and its pharmaceutical products list displayed on our online B2B platform has been verified by the Pipelinepharma team. This ensures seller reputability and reduces sourcing mileage, allowing for a fluent business experience for all involved parties.

Price of Xylometazoline and how to buy:

A cursory search online reveals an approximate cost for wholesale xylometazoline to be £2.62 for 10 ml of 1 mg per 1 ml in the form of spray. For drops, the price is between £1.91 and £2.18 for 0.5 mg and 1 mg per 1 ml. These values are indicated exclusively for the NHS in the UK using the drug tariff Part VIIIA Category C. As such they are only intended to serve as a generalization of the current market conditions in a specific area and a specific form.

Although the prices on the B2B wholesale Pipelinepharma marketplace remain confidential between both B2B parties, the seller may choose to list the desired price to facilitate the online transaction. If so, an ‘Accept’ and ‘Negotiate’ button will be displayed through the online interface, with a ‘Get offer’ button being shown in the absence. This makes it easy to find newly qualified sellers for your pharmaceutical business. Simply use our online search tool, filter by your wanted criteria, and finally select the desired listing.